Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Trial of Celecoxib in the Treatment of Mild Thyroid Eye Disease

NCT02845336 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT02845336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02845336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Trial of Celecoxib in the Treatment of Mild Thyroid Eye Disease
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Terminated
Start date
March 5, 2017
Completion date
June 30, 2019
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid eye disease